-
Navigating the MFN Pricing Era: Strategic Imperatives for Biopharma
Sep 9, 2025, 16:22 PM -
Comprehensive Landscape Assessment of Real-World Databases for HEOR Studies in the Asia-Pacific Region: A Growing Opportunity
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Gemcitabine Nabpaclitaxel Combination, Modified FOLFIRINOX, and SIROX As First-Line Therapy for Pancreatic Cancer
Sep 9, 2025, 16:22 PM -
Predicting the Maximum Fair Price (MFP) From Medicare Negotiations
Sep 9, 2025, 16:22 PM -
Cross-Sectional Cohort Design Offers an Efficient Alternative to Prospective Cohort Design in Real-World Studies (RWS)
Sep 9, 2025, 16:22 PM -
Treatment Patterns and Healthcare Costs of Newly Diagnosed Type 1 Diabetes Patients: A Retrospective Real-World Study of Hospital Care in Tianjin, China
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life (HRQoL) Impacts in Individuals With Hypophosphatasia (HPP): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Clinical Expert Opinion on the Impact of Vosoritide on Health and Function in Children With Achondroplasia
Sep 9, 2025, 16:22 PM -
Outcome Measures Relevant for Assessing Health-Related Quality of Life and Utility in Primary Lateral Sclerosis (PLS)
Sep 9, 2025, 16:22 PM -
Budget Impact Models in CEESP Opinions: A Decade of Insights
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life in Patients Living With Osteosarcoma in Europe: A Systematic Review
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Assessment of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among At-Risk and High-Risk Adults in India
Sep 9, 2025, 16:22 PM -
Multicriteria Health Technology Assessments for High-Cost Oncology Drugs in Peru: A Cross-Sectional Study of RENETSA Records 2023-2024
Sep 9, 2025, 16:22 PM -
Herpes Zoster Hospitalization Rates in Germany: A Retrospective Database Analysis
Sep 9, 2025, 16:22 PM -
Navigating Clinical Trial Design Under the EU Health Technology Assessment Regulation
Sep 9, 2025, 16:22 PM -
Resilient Pharmaceutical Supply Chains in Times of Crisis: A Comparative Analysis of Australia, France, Italy, Spain, and UK
Sep 9, 2025, 16:22 PM -
Real-World Insights Into Breast Cancer in the UK: Findings From UK EHR-Derived Data
Sep 9, 2025, 16:22 PM -
Analysis of the Epidemiological Disease Burden of Endometriosis in Hungary Based on Data From the Global Burden of Disease Study
Sep 9, 2025, 16:22 PM -
From Theory to Practice: Guidance for Identifying and Selecting Mapping Algorithms for Health Economic Models
Sep 9, 2025, 16:22 PM -
Real-World Outcomes From a Pharmacy-Based Awareness and Screening Campaign for HF and CKD: Insights From the Chronic Diseases From A to Z Program
Sep 9, 2025, 16:22 PM
